|   | |
| Clinical data | |
|---|---|
| ATC code | 
 | 
| Legal status | |
| Legal status | |
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C24H23F3N4O2 | 
| Molar mass | 456.469 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
PF-3845 is a selective inhibitor of fatty acid amide hydrolase. [1] It results in increased levels of anandamide and results in cannabinoid receptor-based effects. It has anti-inflammatory action in mice colitis models. Antidiarrheal and antinociceptive effects were also seen in mouse models of pain. [2]
A 2017 study published in the Journal of Psychiatry and Neuroscience found that PF-3845 exerts rapid and long-lasting anti-anxiety effects in mice exposed acutely to stress or chronically to the stress hormone corticosterone. [3]